- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 266.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 75.65M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $9.36M |
| Capex | Q1 2026 · Mar 31, 2025 | $5.86M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $21.08M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $56.59M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.52B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.53B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $848.61M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.43B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.33B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $77.06B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $75.33B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $77.11B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $75.38B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $79.6B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $77.8B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $80.54B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $78.71B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.21 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $57.26M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $30.68M |
| Net Income | Q1 2026 · Mar 31, 2026 | $55.25M |
| Net Income | Q1 2026 · Mar 31, 2025 | $64.79M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $45M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $92.94M |
| Revenue | Q1 2026 · Mar 31, 2026 | $41.63M |
| Revenue | Q1 2026 · Mar 31, 2025 | $20.66M |